Up to 5–10 % of all BC cases and 10–15 % of all ovarian cancer (OC) cases are due to germline mutations in one of the two breast cancer susceptibility genes, BRCA1 [MIM#113705] and BRCA2 [MIM#600185] [2–4]. This evidence concerns the gene BRCA2 and breast cancer.